ORAL ABSTRACT SESSIONS





14 October 2022, Friday

I. Oral Abstract Session

16:40-18:00 (UTC +3)

Moderators: Dr. Fikret Ezberci, Dr. Osman Yüksel



OP1- SURGICAL AND PATHOLOGICAL OUTCOMES IN PATIENTS WITH A CDH-1 MUTATION UNDERGOING TOTAL GASTRECTOMY: A SYSTEMATIC REVIEW - Atousa KHIABANY, Sivesh KAMARAJAH, Meisien LIEW, Ewen GRIFFITHS


OP2- RISK COFACTORS FOR GASTRIC CANCER IN PATIENTS WITH LYNCH SYNDROME - José Pedro VİEİRA DE SOUSA, Ana OLIVEIRA, Miguel ALMEIDA, Fabiana SOUSA, Manuela BAPTISTA, José BARBOSA , Elisabete BARBOSA


OP3- OUR LAPAROSCOPIC GASTRIC CANCER EXPERIENCE IN TURKEY PERIPHERAL HOSPITAL - Ertugrul Gazi ALKURT


OP4- OUR EXPERIENCES AND RESULTS OF STOMACH CANCER SURGERY AT THE NEWLY ESTABLISHED 3rd STAGE BURSA STATE HOSPITAL - Direnc YIGIT


OP5- CLINICOPATHOLOGICAL FEATURES AND SURGICAL RESULTS IN PATIENTS WITH STOMACH CANCER APPLIED TO ROBOTIC SURGERY - Sercan YUKSEL, Ismail CALIKOGLU, Yasin NALBANTLAR, Hasan BEKTAS


OP6- WITH THE EXPANDATION OF ENDOSCOPY AND IMAGING METHODS INCREASED DETECTION RATE OF GIST AND MANAGEMENT - Adil KOYUNCU, Serife Seniha FINCANOGLU


OP7- EVALUATION OF FACTORS RELATED TO CLAVIEN - DINDO 3 AND ABOVE COMPLICATIONS IN PATIENTS UNDERGOING GASTRECTOMY DUE TO GASTRIC CANCER - Orcun YALAV, Ugur TOPAL, Ismail Cem ERAY, Cem Kaan PARSAK


OP8- OUR EXAMINATION RESULTS WITH UPPER GASTROINTESTINAL SYSTEM ENDOSCOPY OF THE STOMACH AND DUODENUM - Habip SARI, Serdar GUMUS


OP9- INCREASED AVERAGE THROMBOCYTE VOLUME, AN INFLAMMATORY HEMATOLOGICAL MARKER CAN IT PREDICT LYMPH NODE METASTASIS IN STOMACH CANCER? - Kaan HUSEMOGLU, Adil KOYUNCU




15 October 2022, Saturday

II. Oral Abstract Session

07:30-08:45 (UTC +3)

Moderators: Dr. Hasan Kaplan, Dr. Ali Güner


OP10- TECHNICAL DETAILS AND SHORT-TERM OUTCOMES OF BILLROTH-I GASTRODUODENOSTOMY: WESTERN EXPERIENCE - Mehmet ULUSAHIN, Arif Burak CEKIC, Murat Emre REIS, Kayahan EYUBOGLU, Adnan GUNDOGDU, Mehmet Arif USTA, Ali GUNER


OP11- OUR ERAS RESULTS IN STOMACH CANCER SURGERY IN SURGICAL ONCOLOGY CLINIC - Pırıltı OZCAN, Murat KALIN, Ozgul DUZGUN, Omer Faruk OZKAN


OP12- OUR INITIAL EXPERIENCE IN ONCOLOGIC LAPAROSCOPIC GASTRIC SURGERY - Mehmet Akif USTUNER, Dogukan DURAK, Oguzhan Fatih AY


OP13- BRAIN METASTASIS FROM GASTRIC ADENOCARCINOMA: A LARGE COMPREHENSIVE POPULATION-BASED COHORT STUDY ON RISK FACTORS AND PROGNOSIS - Lei HUANG


OP14- CHARACTERISTICS AND IN-HOSPITAL OUTCOMES OF GASTRIC CANCER PATIENTS WHO ARE ≥65 YEARS IN A TOP-RANKED HOSPITAL IN CHINA, 2016-2020 - Lei HUANG

 

OP15- ​OUR FIRST PIPAC EXPERIENCE IN AZERBAIJAN USING STANDARDIZED TECHNIQUE WITH THE TOPOL® NEBULIZER DEVICE - Emin BAYRAMOV

 

OP16- PROGNOSTIC SIGNIFICANCE OF METASTATIC LYMPH NODE RATIO IN GASTRIC CANCER: A SINGLE-CENTER ANALYSIS - Muhammer ERGENC, Ece Elif HEKIMOGLU, Tevfik Kıvılcım UPRAK


OP17- RESEARCH PROTOCOL: COMPARISON OF PERIOPERATIVE CHEMOTHERAPY AND SURGERY WITH ADJUVANT THERAPY FOR LOCALLY ADVANCED GASTRIC CANCER - Roman IZRAILOV, Danila MATVECHUK, Nikolay SEMENOV, Oleg VASNEV


OP18- THE EFFECT OF NEOADJUVANT TREATMENT ON SURVIVAL OF STGAE II-III GASTRIC CANCER, Mehmet Güray DUMAN, Ali ALEMDAR, Cemal ULUSOY


OP19- CLINICOPATHOLOGIC DIFFERENCES BETWEEN EARLY-ONSET GASTRIC CANCER AND LATE ONSET GASTRIC CANCER - Habip SARI, Sami BENLI




16 October 2022, Sunday

III. Oral Abstract Session

15:55-17:00 (UTC +3)

Moderators: Dr. Savaş Yakan, Dr. Bülent Çalık



OP20- FACTORS AFFECTING ANASTOMOTIC LEAKAGE AND LEAKAGE MANAGEMENT IN GASTRIC CANCER - Tolga GIRGIN, Can UC, Busra KUCUKATES, Tugce TURK, Tufan GUMUS, Taylan Ozgur SEZER, Ozgur FIRAT, Sinan ERSIN


OP21- EFFECT OF NEOADJUVAN TREATMENT TO SURGERY ON PATHOLOGICAL RESPONSE IN GASTRIC CANCER: PRELIMINARY STUDY - Enver ILHAN, Orhan UREYEN, Asuman ARGON, Ozlem OZDEMIR, Emrehan INCI, Abidin Gazi ALAGOZ


OP22- DEMOGRAPHIC AND CLINICOPATHOLOGICAL EVALUATION OF OUR PATIENTS WITH GASTRIC TUMOR: COVID-19 PANDEMIC AND NON-PANDEMIC RETROSPECTIVE STUDY - Omer CAGLIYAN, Ahmet Mucteba OZTURK, Sedat TAN, Yasemin SAHIN, Erkan OYMACI, Ahmet Deniz UCAR, Mehmet YILDIRIM


OP23- PROGNOSTIC FACTORS IN STOMACH GASTROINTESTINAL SYSTEM STROMAL TUMORS - Can UC, Tufan GUMUS, Busra KUCUKATES, Tolga GIRGIN, Taylan Ozgur SEZER, Ozgur FIRAT, Sinan ERSIN


OP24- CLINICOPATHOLOGICAL CHARACTERISTICS OF YOUNG ADULT (<40 YEARS OLD) GASTRIC CANCER PATIENTS - Gokalp OKUTMehmet Alperen UGURMurat KARATAS, Erkan OYMACI, Orhan UREYEN, Mehmet YILDIRIM, Savas YAKAN, Enver ILHAN


OP25- CLINICOPATHOLOGICAL FEATURES, PROGNOSIS AND SURVIVAL OUTCOMES OF STOMACH CANCER IN YOUNG PATIENTS - Emran Kuzey AVCI, Murat GUNER, Cengiz AYDIN

 

OP26- OVERALL SURVIVAL ANALYSIS OF OUR PATIENTS WITH GASTRIC CANCER WHO HAVE NEOADJUVANT CHEMOTHERAPY, Seval AKAY, Mustafa DEĞİRMENCİ, Hamza Ekmel NAZLI, Özlem ÖZDEMİR , Cengiz YILMAZ, Orhan ÜREYEN, Enver İLHAN


OP27- H.PYLORI AS A PREDICTIVE FACTOR FOR GASTRIC MALIGNENCIES: SPECTRUM OF SLEEVE GASTRECTOMY SPECIMENS - Ahmet CEKIC, Ahmet Mucteba OZTURK, Erkan OYMACI, Funda TASLI, Mehmet YILDIRIM


OP28- METASTATIC LYMPH NODE RATIO AS A PROGNOSTIC FACTOR IN GASTRIC ADENOCARCINOMA - Tufan GUMUS, Can UC, Recep TEMEL, Taylan Ozgur SEZER, Ozgur FIRAT, Sinan ERSIN


OP29- THE OUTCOMES OF GASTRIC CANCER SURGERY IN ELDERLY PATIENTS - Osman BOZBIYIK, Can UC, Sinan ERSIN


OP30- ANALYSIS OF GASTRIC ADENOCARCINOMA WITH NEUROENDOCRINE DIFFERANTIATION IN PATIENTS WHO UNDERWENT GASTRIC CANCER SURGERY - Murat GUNER, Cengiz AYDIN


OP31HYDRO BT IN DIAGNOSIS AND FOLLOW-UP OF STOMACH CANCER - Recep Yılmaz BAYRAKTARLI


OP32- SHOULD DIAGNOSTIC LAPAROSCOPY BE PERFORMED PRIOR TO OPERATION IN GASTRIC CANCER? - Berkay DEMIRORS, Mehmet Akıf ÜSTÜNER, Doğukan DURAK, Yurdakul Deniz FIRAT